title: How should chronic hepatitis B virus infection be managed in HIV-hepatitis B virus-coinfected patients not eligible for concomitant antiretroviral therapy?
authors.forename: Hélène
authors.initials: H
authors.lastname: Castel
authors.forename: Laurence
authors.initials: L
authors.lastname: Bocket
authors.forename: Catherine
authors.initials: C
authors.lastname: Tamalet
authors.forename: Marc
authors.initials: M
authors.lastname: Bourlière
authors.forename: Yazdan
authors.initials: Y
authors.lastname: Yazdanpanah
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000998:Antiviral Agents / Q000008:administration & dosage*; D005260:Female; D006147:Guanine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D015497:HIV-1; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D008297:Male; D017410:Practice Guidelines as Topic
chemical_list: D000998:Antiviral Agents; C413685:entecavir; D006147:Guanine